The Dual Inhibition of Met and EGFR by ME22S, a Novel Met/EGFR Bispecific Monoclonal Antibody, Suppresses the Proliferation and Invasion of Laryngeal Cancer

Title
The Dual Inhibition of Met and EGFR by ME22S, a Novel Met/EGFR Bispecific Monoclonal Antibody, Suppresses the Proliferation and Invasion of Laryngeal Cancer
Authors
Keywords
Hepatocyte Growth Factor, Gefitinib, Laryngeal Carcinoma, Bispecific Antibody, SNU899 Cell
Journal
ANNALS OF SURGICAL ONCOLOGY
Volume 23, Issue 6, Pages 2046-2053
Publisher
Springer Nature
Online
2016-01-26
DOI
10.1245/s10434-015-5084-0

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search